Contact your GP if you experience: Persistent insomnia lasting more than three months despite implementing sleep hygiene measures, or sooner if it severely affects your daily functioning Severe sleep deprivation that impairs your ability to function safely during daytime activities, particularly if operating machinery or driving Mood changes accompanying sleep disturbance, including persistent low mood, anxiety, or irritability that may indicate depression Impact on quality of life , including inability to work, maintain relationships, or engage in usual activities Seek urgent medical attention if you experience: Chest pain or palpitations during sleep (call 999) Severe breathing difficulties during sleep (call 999) Thoughts of self-harm or suicide (contact your GP urgently, call NHS 111, or 999 in an emergency) Your healthcare provider may conduct a thorough assessment to determine whether the sleep disturbance is related to Wegovy, an underlying condition, or other factors

These predispositions can help your provider contextualize monitoring intensity and realistic BP reduction timelines
A licensed healthcare professional administers the dose-usually by slow intravenous push or diluted IV infusion
In early trials, a transient increase in heart rate was observed around the 24-week mark before gradually declining
Readers can review current FDA guidance on compounded medications directly at FDA.gov
Our goal is to ensure Islanders have access to the most effective coverage while maintaining the sustainability of our drug programs. GLP-1 drugs can help prepare for surgery Evers says using GLP-1 medications can be beneficial in conjunction with bariatric surgery a procedure that reduces the size of the stomach to help those with obesity manage their weight and overall health